Neo Performance Materials Reports Fourth Quarter 2025 Results
19 mars, 12:00
19 mars, 12:00
Neo Performance Materials Reports Fourth Quarter 2025 Results
Canada NewsWire
TORONTO, March 19, 2026
Neo Exceeds 2025 Guidance and Advances Strategic Growth Initiatives
TORONTO , March 19, 2026 /CNW/ - Neo Performance Materials Inc. (" Neo " or the " Company ") (TSX: NEO) (OTCQX: NOPMF) today announced its financial results for the fourth quarter and full year 2025. Neo's financial statements and management's discussion and analysis (" MD&A ") for the year ended December 31, 2025, are available at neomaterials.com and on SEDAR+ at sedarplus.ca . All financial amounts in this news release and the Company's financial disclosures are in United States dollars, unless otherwise stated.
"2025 was a year of meaningful execution and strategic progress for Neo. We delivered full-year Adjusted EBITDA of $75.6million, exceeding our previously issued guidance, while advancing key initiatives that strengthen our long-term growth platform," said Rahim Suleman, President and Chief Executive Officer of Neo .
"Across our businesses we saw strong demand from structural growth drivers including electrification, automation, AI infrastructure, and aerospace. During the year we also achieved several important strategic milestones, most notably the continued execution of our European platform, including the grand opening of our European Permanent Magnet facility, more program awards, ongoing progress toward commercializing magnet production and advancing our heavy rare earth separation capability in Europe. In addition, we delivered double‑digit growth in our Emission Catalyst platform and completed the divestiture of our legacy China separation assets, further simplifying the portfolio and sharpening our focus on higher‑value, strategically differentiated businesses."
"As global supply chains increasingly prioritize security and localization for critical materials, Neo's integrated platform positions us well to serve our customers across magnets, specialty materials, and rare metals. With strong operational momentum and a simplified portfolio focused on higher-value businesses, we are entering 2026 well positioned to continue delivering disciplined growth and long-term value for shareholders."
Strategic and Operational Highlights
__________________________________ |
(1) Neo reports non-IFRS financial measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Information on non-IFRS financial measures is included in the "Non-IFRS Financial Measures" section of this news release and in the most recent MD&A, available at neomaterials.com and on SEDAR+ at sedarplus.ca . |
Outlook
Neo enters 2026 with strong operational momentum and continued progress across its strategic growth initiatives.
The Company expects continued demand across key end markets supported by structural trends including electrification, automation, artificial intelligence infrastructure and aerospace applications. Governments and customers are increasingly focused on developing secure and localized supply chains for critical materials.
Neo's European Permanent Magnet facility continues to advance through qualification milestones, with commercial production expected to ramp during 2026. The Company expects to progress multiple customer magnet programs toward start of production, scale volumes as the year advances, and announce additional magnet awards in Europe. Neo is also advancing planning activities for a potential Phase 1b expansion, which would increase annual capacity from approximately 2,000 metric tonnes to 5,000 metric tonnes. In parallel, the Company is advancing its heavy rare earth separation capability at Silmet to further strengthen its integrated critical materials platform.
Based on current market conditions and operational performance, Neo has established 2026 Adjusted EBITDA guidance of $75 million to $80 million.
Consolidated Financial Highlights
Segment Highlights
Magnequench Delivers Strong Volume Growth and Strategic Progress:
Chemicals & Oxides Delivers Significant Earnings Growth and Portfolio Transformation:
Rare Metals Maintains Solid Performance Amid Hafnium Price Normalization:
Conference Call
Neo's fourth quarter 2025 financial results webcast and conference call details are provided below.
Webcast and Conference Call Details:
Date: Thursday, March 19, 2026
Time : 10:00 AM ET | 7:00 AM PT
Listen Only Webcast:Webcast Link
Conference call: +1 (416) 945-7677 (local) or 1 (888) 699-1199 (toll-free long distance) or by visiting Dial-in Link .
A replay of the webcast will be available by clicking on this LINK and will be archived on the Company's website for a limited period. A teleconference recording may be accessed by calling 1(289) 819-1450 (local) or 1 (888) 660-6345 (toll-free long distance) and entering passcode 65901# until April 14, 2026.
Non-IFRS Financial Measures
This new release refers to certain specified financial measures and ratios, including non-IFRS financial measures and ratios such as " EBITDA ", " Adjusted EBITDA ", " Adjusted EBITDA Margin ", " Adjusted Net Income ", " Adjusted Earnings per Share ", " Free Cash Flow " and " Gross Margin ". These specified financial measures are not recognized measures under International Financial Reporting Standards (" IFRS ") accounting standards as issued by the International Accounting Standards Board, do not have a standardized meaning prescribed by IFRS, and may not be comparable to similar measures presented by other companies. Rather, these specified financial measures (" non-IFRS financial measures ") are provided as additional information to complement IFRS financial measures by providing further understanding of Neo's results of operations from management's perspective. Neo's definitions of non-IFRS financial measures used in this news release may not be the same as the definitions for such measures used by other companies in their reporting.
Specified financial measures such as non-IFRS financial measures and ratios have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of Neo's financial information reported under IFRS. Neo uses specified financial measures to provide investors with supplemental measures of its base-line operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Neo believes that securities analysts, investors and other interested parties frequently use specified financial measures such as non-IFRS financial measures and ratios in the evaluation of issuers. Neo's management also uses non-IFRS financial measures and ratios to facilitate operating performance comparisons from period to period. Readers are cautioned that these measures should not be construed as an alternative to their nearest or directly comparable financial measures determined in accordance with IFRS as an indication of Neo's financial performance. For further information on how Neo defines such specified financial measures, including non-IFRS financial measures and ratios and, where applicable, their reconciliations to the nearest comparable IFRS measures, please see the "Non-IFRS Financial Measures" section of Neo's MD&A for the year ended December 31, 2025, which is hereby incorporated by reference into this news release, and at neomaterials.com and on SEDAR+ at sedarplus.ca .
About Neo Performance Materials
Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo's advanced industrial materials, rare earth magnetic powders and magnets, specialty chemicals, metals, and alloys are critical to the performance of many everyday products and emerging technologies across industries. Neo's products help to deliver the technologies of tomorrow to consumers today.
As at December 31, 2025, Neo has 1,524 employees and a global platform that includes manufacturing facilities located in Canada, China, Estonia, Germany, Thailand, and the United Kingdom (" UK ") as well as one dedicated research and development (" R&D ") centre in Singapore. Neo has three operating segments: Magnequench, Chemicals & Oxides (" C&O ") and Rare Metals, as well as the Corporate segment.
Cautionary Statements Regarding Forward Looking Statements
This news release contains "forward-looking information", within the meaning of applicable securities laws in Canada. Forward-looking information may relate to future events or future performance of Neo. All statements in this news release, other than statements of historical facts, with respect to Neo's objectives and goals, as well as statements with respect to its beliefs, plans, objectives, expectations, anticipations, estimates, and intentions are forward-looking information.
Specific forward-looking information in this news release include, but are not limited to: expectations regarding certain of Neo's future results and information, including, among other things; revenue; expenses; growth prospects; capital expenditures; and operations; risk factors relating to national or international economies, geopolitical risk and other risks present in the jurisdictions in which Neo, its customers, its suppliers, and/or its logistics partners operate; statements with respect to current and future market trends that may directly or indirectly impact sales and revenue of Neo, including but not limited to the price of rare earth elements; expected use of cash balances; continuation of prudent management of working capital; source of funds for ongoing business requirements and capital investments; expectations regarding sufficiency of the allowance for uncollectible accounts and inventory provisions; analysis regarding sensitivity of the business to changes in exchange rates and changes in rare earth prices; impact of recently adopted accounting pronouncements; risk factors relating to intellectual property protection and intellectual property litigation; expectations regarding demand for products and applications; expectations regarding the growth of superalloy and superconductor materials; anticipated commercial launch of Neo's new Permanent Magnet facility in Europe and related commercial production estimates, forecasted budget, commissioning and costs associated with the facility; Neo's requalified product portfolio, including the NAMCO product portfolio; expectations regarding tariffs and export restrictions; securing new automotive customer agreements for permanent magnet and emission catalyst facilities; expectations concerning the continued growth of the Magnequench project and improvements in operations; expectations concerning any remediation efforts to Neo's design of its internal controls over financial reporting and disclosure controls and procedures; and Neo's 2026 guidance and the assumptions relating thereto.
Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates" or "believes", or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. This information involves risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information.
Additionally, Neo's 2026 guidance reflects Neo's expectations as to financial performance in 2026 based on assumptions which Neo believes to be reasonable as of the date of this news release including but not limited to continued Magnequench growth, operational improvements in C&O, relative stability in rare earth pricing, continued strong hafnium demand alongside elevated pricing and tight raw material supply conditions, reduction in operating expenses, expectations regarding tariffs and export controls, and securing new customer agreements for permanent magnet and emission catalyst facilities. Neo believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this discussion and analysis should not be unduly relied upon. For more information on Neo, investors should review filings available under Neo's profile at sedarplus.ca.
Information contained in forward-looking statements in this news release is provided as of the date hereof and Neo disclaims any obligation to update any forward-looking information, whether as a result of new information or future events or results, except to the extent required by applicable securities laws.
HIGHLIGHTS OF FOURTH QUARTER 2025 CONSOLIDATED PERFORMANCE
($000s, except per share information) | Three Months Ended
| Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Revenue | ||||
Magnequench | $ 54,956 | $ 43,500 | $ 204,555 | $ 176,649 |
C&O | 29,252 | 43,606 | 135,030 | 146,516 |
Rare Metals | 39,686 | 48,441 | 147,665 | 156,206 |
Corporate / Eliminations | (3,624) | (644) | (8,457) | (3,543) |
Consolidated Revenue | $ 120,270 | $ 134,903 | $ 478,793 | $ 475,828 |
Operating Income (Loss) | ||||
Magnequench | $ (4,530) | $ 2,018 | $ 1,486 | $ 10,123 |
C&O | 5,330 | 27 | 17,480 | (2,854) |
Rare Metals | 11,622 | 16,910 | 40,727 | 50,134 |
Corporate / Eliminations | (6,831) | (6,600) | (27,939) | (22,102) |
Consolidated Operating Income | $ 5,591 | $ 12,355 | $ 31,754 | $ 35,301 |
Adjusted EBITDA | ||||
Magnequench | $ 6,017 | $ 6,824 | $ 28,377 | $ 25,528 |
C&O | 7,093 | 1,350 | 23,444 | 4,924 |
Rare Metals | 12,288 | 17,383 | 43,200 | 51,762 |
Corporate / Eliminations | (5,031) | (4,866) | (19,375) | (17,816) |
Consolidated Adjusted EBITDA | $ 20,367 | $ 20,691 | $ 75,646 | $ 64,398 |
Net Loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Loss per share attributable to common shareholders | ||||
Basic and diluted | $ (0.38) | $ (0.29) | $ (0.24) | $ (0.31) |
Cash spent on property, plant and equipment and intangible assets | $ 3,518 | $ 12,019 | $ 31,664 | $ 64,202 |
Cash taxes (refunded) paid | $ (863) | $ 3,579 | $ 10,328 | $ 22,411 |
Dividends paid to shareholders | $ 2,959 | $ 3,062 | $ 12,053 | $ 12,330 |
Dividend paid to Buss & Buss minority shareholder | $ — | $ 7,967 | $ 7,343 | $ 15,183 |
Repurchase of common shares under the NCIB | $ 106 | $ — | $ 3,995 | $ 2,250 |
As at: | December 31, 2025 | December 31, 2024 | ||
Cash and cash equivalents | $ 38,360 | $ 85,489 | ||
Short-term debt, bank advances & other | $ 12,949 | $ 2,740 | ||
Total debt | $ 101,804 | $ 71,536 |
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
($000s) | December 31, 2025 | December 31, 2024 |
ASSETS | ||
Cash and cash equivalents | $ 38,360 | $ 85,489 |
Accounts receivable | 93,186 | 61,232 |
Inventories | 205,405 | 139,321 |
Income taxes receivable | 2,196 | 4,108 |
Assets held for sale | — | 40,949 |
Other current assets | 24,070 | 24,264 |
Total current assets | 363,217 | 355,363 |
Property, plant and equipment | 198,440 | 178,925 |
Intangible assets | 30,857 | 33,580 |
Goodwill | 65,857 | 64,029 |
Equity method investments | 17,116 | 16,330 |
Other investments | 3,496 | 217 |
Deferred tax assets | 2,799 | 4,045 |
Other non-current assets | 3,105 | 765 |
Total non-current assets | 321,670 | 297,891 |
Total assets | $ 684,887 | $ 653,254 |
LIABILITIES AND EQUITY | ||
Short-term debt | $ 12,949 | $ 2,740 |
Accounts payable and other accrued charges | 95,844 | 69,546 |
Income taxes payable | 15,120 | 10,463 |
Provisions | 3,470 | 12,512 |
Lease obligations | 564 | 1,229 |
Derivative liability | 60,596 | 47,416 |
Current portion of long-term debt | 9,343 | 4,610 |
Liabilities directly associated with the assets held for sale | — | 10,254 |
Other current liabilities | 252 | 647 |
Total current liabilities | 198,138 | 159,417 |
Long-term debt | 79,512 | 64,186 |
Derivative liability | 1,407 | 1,311 |
Provisions | 2,392 | 6,726 |
Deferred tax liabilities | 9,405 | 12,646 |
Lease obligations | 3,170 | 3,244 |
Other non-current liabilities | 395 | 842 |
Total non-current liabilities | 96,281 | 88,955 |
Total liabilities | 294,419 | 248,372 |
Non-controlling interest | 464 | 2,714 |
Equity attributable to common shareholders | 390,004 | 402,168 |
Total equity | 390,468 | 404,882 |
Total liabilities and equity | $ 684,887 | $ 653,254 |
See accompanying notes to this table in Neo's audited consolidated financial statements as at December 31, 2025 and for the year then ended.
CONSOLIDATED RESULTS OF OPERATIONS
($000s) | Three Months Ended December 31, | Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Revenue | $ 120,270 | $ 134,903 | $ 478,793 | $ 475,828 |
Cost of sales | ||||
Cost excluding depreciation and amortization | 82,548 | 94,466 | 337,006 | 343,315 |
Depreciation and amortization | 2,021 | 2,512 | 7,963 | 8,553 |
Gross profit | 35,701 | 37,925 | 133,824 | 123,960 |
Expenses | ||||
Selling, general and administrative | 17,763 | 16,446 | 64,382 | 61,400 |
Share-based compensation | 3,428 | 770 | 11,958 | 3,060 |
Depreciation and amortization | 1,744 | 1,796 | 7,043 | 7,192 |
Research and development | 7,175 | 6,894 | 18,687 | 16,869 |
(Reversal of impairment) / impairment of assets | — | (336) | — | 138 |
Total expenses | 30,110 | 25,570 | 102,070 | 88,659 |
Operating income | 5,591 | 12,355 | 31,754 | 35,301 |
Other (expense) income | (7,270) | 507 | (11,753) | 3,405 |
Finance cost, net | (9,535) | (13,882) | (23,789) | (27,488) |
Foreign exchange gain (loss) | (559) | (4,236) | 7,407 | (4,268) |
Income from operations before income taxes and equity income of associates | (11,773) | (5,256) | 3,619 | 6,950 |
Income tax expense | (3,874) | (7,571) | (14,402) | (17,945) |
Loss from operations before equity income (loss) of associates | (15,647) | (12,827) | (10,783) | (10,995) |
Equity income (loss) of associates (net of income tax) | 19 | 790 | 814 | (2,021) |
Net loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Attributable to: | ||||
Common shareholders | $ (15,639) | $ (12,050) | $ (9,984) | $ (12,946) |
Non-controlling interest | 11 | 13 | 15 | (70) |
Loss per share attributable to common shareholders: | ||||
Basic | $ (0.38) | $ (0.29) | $ (0.24) | $ (0.31) |
Diluted | $ (0.38) | $ (0.29) | $ (0.24) | $ (0.31) |
For additional information, refer to Neo's MD&A for the year ended December 31, 2025.
RECONCILIATION OF NET INCOME TO EBITDA, ADJUSTED EBITDA AND FREE CASH FLOW
($000s, except volume) | Three Months Ended December 31, | Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Sales volume (tonnes) | 2,988 | 3,157 | 13,216 | 12,413 |
Revenue | $ 120,270 | $ 134,903 | $ 478,793 | $ 475,828 |
Net Loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Add back: | ||||
Finance costs, net | 9,535 | 13,882 | 23,789 | 27,488 |
Income tax expense | 3,874 | 7,571 | 14,402 | 17,945 |
Depreciation and amortization included in cost of sales | 2,021 | 2,512 | 7,963 | 8,553 |
Depreciation and amortization included in operating expenses | 1,744 | 1,796 | 7,043 | 7,192 |
EBITDA | 1,546 | 13,724 | 43,228 | 48,162 |
Adjustments to EBITDA: | ||||
Other expense (income) | 7,270 | (507) | 11,753 | (3,405) |
Foreign exchange loss (gain) | 559 | 4,236 | (7,407) | 4,268 |
Equity (income) loss of associates | (19) | (790) | (814) | 2,021 |
Share-based compensation | 3,428 | 770 | 11,958 | 3,060 |
Project start-up and transition costs | 7,583 | 3,594 | 16,928 | 10,154 |
Impairment of assets | — | (336) | — | 138 |
Adjusted EBITDA | $ 20,367 | $ 20,691 | $ 75,646 | $ 64,398 |
Adjusted EBITDA Margin | 16.9 % | 15.3 % | 15.8 % | 13.5 % |
Less: | ||||
Capital expenditures | $ 4,822 | $ 22,818 | $ 23,269 | $ 80,205 |
Free Cash Flow | $ 15,545 | $ (2,127) | $ 52,377 | $ (15,807) |
For additional information, refer to Neo's MD&A for the year ended December 31, 2025.
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED NET INCOME
($000s) | Three Months Ended December 31, | Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Net Loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Adjustments to net loss: | ||||
Foreign exchange loss (gain) | 559 | 4,236 | (7,407) | 4,268 |
(Reversal of) Impairment of assets | — | (336) | — | 138 |
Share-based compensation | 3,428 | 770 | 11,958 | 3,060 |
Project start-up & transition costs | 7,583 | 3,594 | 16,928 | 10,154 |
Other items included in other expense (income) | 5,094 | (1,245) | 9,722 | (3,244) |
Tax impact of the above items | (470) | 138 | (770) | 545 |
Adjusted net (loss) income | $ 566 | $ (4,880) | $ 20,462 | $ 1,905 |
Attributable to: | ||||
Common shareholders | $ 555 | $ (4,893) | $ 20,447 | $ 1,975 |
Non-controlling interest | 11 | 13 | 15 | (70) |
Weighted average number of common shares outstanding: | ||||
Basic and diluted (000s) | 41,599 | 41,759 | 41,699 | 41,773 |
Adjusted earnings per share attributable to common shareholders: | ||||
Basic and diluted | $ 0.01 | $ (0.12) | $ 0.49 | $ 0.05 |
For additional information, refer to Neo's MD&A for the year ended December 31, 2025.
SOURCE Neo Performance Materials, Inc.

19 mars, 12:00
Neo Performance Materials Reports Fourth Quarter 2025 Results
Canada NewsWire
TORONTO, March 19, 2026
Neo Exceeds 2025 Guidance and Advances Strategic Growth Initiatives
TORONTO , March 19, 2026 /CNW/ - Neo Performance Materials Inc. (" Neo " or the " Company ") (TSX: NEO) (OTCQX: NOPMF) today announced its financial results for the fourth quarter and full year 2025. Neo's financial statements and management's discussion and analysis (" MD&A ") for the year ended December 31, 2025, are available at neomaterials.com and on SEDAR+ at sedarplus.ca . All financial amounts in this news release and the Company's financial disclosures are in United States dollars, unless otherwise stated.
"2025 was a year of meaningful execution and strategic progress for Neo. We delivered full-year Adjusted EBITDA of $75.6million, exceeding our previously issued guidance, while advancing key initiatives that strengthen our long-term growth platform," said Rahim Suleman, President and Chief Executive Officer of Neo .
"Across our businesses we saw strong demand from structural growth drivers including electrification, automation, AI infrastructure, and aerospace. During the year we also achieved several important strategic milestones, most notably the continued execution of our European platform, including the grand opening of our European Permanent Magnet facility, more program awards, ongoing progress toward commercializing magnet production and advancing our heavy rare earth separation capability in Europe. In addition, we delivered double‑digit growth in our Emission Catalyst platform and completed the divestiture of our legacy China separation assets, further simplifying the portfolio and sharpening our focus on higher‑value, strategically differentiated businesses."
"As global supply chains increasingly prioritize security and localization for critical materials, Neo's integrated platform positions us well to serve our customers across magnets, specialty materials, and rare metals. With strong operational momentum and a simplified portfolio focused on higher-value businesses, we are entering 2026 well positioned to continue delivering disciplined growth and long-term value for shareholders."
Strategic and Operational Highlights
__________________________________ |
(1) Neo reports non-IFRS financial measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Information on non-IFRS financial measures is included in the "Non-IFRS Financial Measures" section of this news release and in the most recent MD&A, available at neomaterials.com and on SEDAR+ at sedarplus.ca . |
Outlook
Neo enters 2026 with strong operational momentum and continued progress across its strategic growth initiatives.
The Company expects continued demand across key end markets supported by structural trends including electrification, automation, artificial intelligence infrastructure and aerospace applications. Governments and customers are increasingly focused on developing secure and localized supply chains for critical materials.
Neo's European Permanent Magnet facility continues to advance through qualification milestones, with commercial production expected to ramp during 2026. The Company expects to progress multiple customer magnet programs toward start of production, scale volumes as the year advances, and announce additional magnet awards in Europe. Neo is also advancing planning activities for a potential Phase 1b expansion, which would increase annual capacity from approximately 2,000 metric tonnes to 5,000 metric tonnes. In parallel, the Company is advancing its heavy rare earth separation capability at Silmet to further strengthen its integrated critical materials platform.
Based on current market conditions and operational performance, Neo has established 2026 Adjusted EBITDA guidance of $75 million to $80 million.
Consolidated Financial Highlights
Segment Highlights
Magnequench Delivers Strong Volume Growth and Strategic Progress:
Chemicals & Oxides Delivers Significant Earnings Growth and Portfolio Transformation:
Rare Metals Maintains Solid Performance Amid Hafnium Price Normalization:
Conference Call
Neo's fourth quarter 2025 financial results webcast and conference call details are provided below.
Webcast and Conference Call Details:
Date: Thursday, March 19, 2026
Time : 10:00 AM ET | 7:00 AM PT
Listen Only Webcast:Webcast Link
Conference call: +1 (416) 945-7677 (local) or 1 (888) 699-1199 (toll-free long distance) or by visiting Dial-in Link .
A replay of the webcast will be available by clicking on this LINK and will be archived on the Company's website for a limited period. A teleconference recording may be accessed by calling 1(289) 819-1450 (local) or 1 (888) 660-6345 (toll-free long distance) and entering passcode 65901# until April 14, 2026.
Non-IFRS Financial Measures
This new release refers to certain specified financial measures and ratios, including non-IFRS financial measures and ratios such as " EBITDA ", " Adjusted EBITDA ", " Adjusted EBITDA Margin ", " Adjusted Net Income ", " Adjusted Earnings per Share ", " Free Cash Flow " and " Gross Margin ". These specified financial measures are not recognized measures under International Financial Reporting Standards (" IFRS ") accounting standards as issued by the International Accounting Standards Board, do not have a standardized meaning prescribed by IFRS, and may not be comparable to similar measures presented by other companies. Rather, these specified financial measures (" non-IFRS financial measures ") are provided as additional information to complement IFRS financial measures by providing further understanding of Neo's results of operations from management's perspective. Neo's definitions of non-IFRS financial measures used in this news release may not be the same as the definitions for such measures used by other companies in their reporting.
Specified financial measures such as non-IFRS financial measures and ratios have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of Neo's financial information reported under IFRS. Neo uses specified financial measures to provide investors with supplemental measures of its base-line operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Neo believes that securities analysts, investors and other interested parties frequently use specified financial measures such as non-IFRS financial measures and ratios in the evaluation of issuers. Neo's management also uses non-IFRS financial measures and ratios to facilitate operating performance comparisons from period to period. Readers are cautioned that these measures should not be construed as an alternative to their nearest or directly comparable financial measures determined in accordance with IFRS as an indication of Neo's financial performance. For further information on how Neo defines such specified financial measures, including non-IFRS financial measures and ratios and, where applicable, their reconciliations to the nearest comparable IFRS measures, please see the "Non-IFRS Financial Measures" section of Neo's MD&A for the year ended December 31, 2025, which is hereby incorporated by reference into this news release, and at neomaterials.com and on SEDAR+ at sedarplus.ca .
About Neo Performance Materials
Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo's advanced industrial materials, rare earth magnetic powders and magnets, specialty chemicals, metals, and alloys are critical to the performance of many everyday products and emerging technologies across industries. Neo's products help to deliver the technologies of tomorrow to consumers today.
As at December 31, 2025, Neo has 1,524 employees and a global platform that includes manufacturing facilities located in Canada, China, Estonia, Germany, Thailand, and the United Kingdom (" UK ") as well as one dedicated research and development (" R&D ") centre in Singapore. Neo has three operating segments: Magnequench, Chemicals & Oxides (" C&O ") and Rare Metals, as well as the Corporate segment.
Cautionary Statements Regarding Forward Looking Statements
This news release contains "forward-looking information", within the meaning of applicable securities laws in Canada. Forward-looking information may relate to future events or future performance of Neo. All statements in this news release, other than statements of historical facts, with respect to Neo's objectives and goals, as well as statements with respect to its beliefs, plans, objectives, expectations, anticipations, estimates, and intentions are forward-looking information.
Specific forward-looking information in this news release include, but are not limited to: expectations regarding certain of Neo's future results and information, including, among other things; revenue; expenses; growth prospects; capital expenditures; and operations; risk factors relating to national or international economies, geopolitical risk and other risks present in the jurisdictions in which Neo, its customers, its suppliers, and/or its logistics partners operate; statements with respect to current and future market trends that may directly or indirectly impact sales and revenue of Neo, including but not limited to the price of rare earth elements; expected use of cash balances; continuation of prudent management of working capital; source of funds for ongoing business requirements and capital investments; expectations regarding sufficiency of the allowance for uncollectible accounts and inventory provisions; analysis regarding sensitivity of the business to changes in exchange rates and changes in rare earth prices; impact of recently adopted accounting pronouncements; risk factors relating to intellectual property protection and intellectual property litigation; expectations regarding demand for products and applications; expectations regarding the growth of superalloy and superconductor materials; anticipated commercial launch of Neo's new Permanent Magnet facility in Europe and related commercial production estimates, forecasted budget, commissioning and costs associated with the facility; Neo's requalified product portfolio, including the NAMCO product portfolio; expectations regarding tariffs and export restrictions; securing new automotive customer agreements for permanent magnet and emission catalyst facilities; expectations concerning the continued growth of the Magnequench project and improvements in operations; expectations concerning any remediation efforts to Neo's design of its internal controls over financial reporting and disclosure controls and procedures; and Neo's 2026 guidance and the assumptions relating thereto.
Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates" or "believes", or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. This information involves risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information.
Additionally, Neo's 2026 guidance reflects Neo's expectations as to financial performance in 2026 based on assumptions which Neo believes to be reasonable as of the date of this news release including but not limited to continued Magnequench growth, operational improvements in C&O, relative stability in rare earth pricing, continued strong hafnium demand alongside elevated pricing and tight raw material supply conditions, reduction in operating expenses, expectations regarding tariffs and export controls, and securing new customer agreements for permanent magnet and emission catalyst facilities. Neo believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this discussion and analysis should not be unduly relied upon. For more information on Neo, investors should review filings available under Neo's profile at sedarplus.ca.
Information contained in forward-looking statements in this news release is provided as of the date hereof and Neo disclaims any obligation to update any forward-looking information, whether as a result of new information or future events or results, except to the extent required by applicable securities laws.
HIGHLIGHTS OF FOURTH QUARTER 2025 CONSOLIDATED PERFORMANCE
($000s, except per share information) | Three Months Ended
| Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Revenue | ||||
Magnequench | $ 54,956 | $ 43,500 | $ 204,555 | $ 176,649 |
C&O | 29,252 | 43,606 | 135,030 | 146,516 |
Rare Metals | 39,686 | 48,441 | 147,665 | 156,206 |
Corporate / Eliminations | (3,624) | (644) | (8,457) | (3,543) |
Consolidated Revenue | $ 120,270 | $ 134,903 | $ 478,793 | $ 475,828 |
Operating Income (Loss) | ||||
Magnequench | $ (4,530) | $ 2,018 | $ 1,486 | $ 10,123 |
C&O | 5,330 | 27 | 17,480 | (2,854) |
Rare Metals | 11,622 | 16,910 | 40,727 | 50,134 |
Corporate / Eliminations | (6,831) | (6,600) | (27,939) | (22,102) |
Consolidated Operating Income | $ 5,591 | $ 12,355 | $ 31,754 | $ 35,301 |
Adjusted EBITDA | ||||
Magnequench | $ 6,017 | $ 6,824 | $ 28,377 | $ 25,528 |
C&O | 7,093 | 1,350 | 23,444 | 4,924 |
Rare Metals | 12,288 | 17,383 | 43,200 | 51,762 |
Corporate / Eliminations | (5,031) | (4,866) | (19,375) | (17,816) |
Consolidated Adjusted EBITDA | $ 20,367 | $ 20,691 | $ 75,646 | $ 64,398 |
Net Loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Loss per share attributable to common shareholders | ||||
Basic and diluted | $ (0.38) | $ (0.29) | $ (0.24) | $ (0.31) |
Cash spent on property, plant and equipment and intangible assets | $ 3,518 | $ 12,019 | $ 31,664 | $ 64,202 |
Cash taxes (refunded) paid | $ (863) | $ 3,579 | $ 10,328 | $ 22,411 |
Dividends paid to shareholders | $ 2,959 | $ 3,062 | $ 12,053 | $ 12,330 |
Dividend paid to Buss & Buss minority shareholder | $ — | $ 7,967 | $ 7,343 | $ 15,183 |
Repurchase of common shares under the NCIB | $ 106 | $ — | $ 3,995 | $ 2,250 |
As at: | December 31, 2025 | December 31, 2024 | ||
Cash and cash equivalents | $ 38,360 | $ 85,489 | ||
Short-term debt, bank advances & other | $ 12,949 | $ 2,740 | ||
Total debt | $ 101,804 | $ 71,536 |
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
($000s) | December 31, 2025 | December 31, 2024 |
ASSETS | ||
Cash and cash equivalents | $ 38,360 | $ 85,489 |
Accounts receivable | 93,186 | 61,232 |
Inventories | 205,405 | 139,321 |
Income taxes receivable | 2,196 | 4,108 |
Assets held for sale | — | 40,949 |
Other current assets | 24,070 | 24,264 |
Total current assets | 363,217 | 355,363 |
Property, plant and equipment | 198,440 | 178,925 |
Intangible assets | 30,857 | 33,580 |
Goodwill | 65,857 | 64,029 |
Equity method investments | 17,116 | 16,330 |
Other investments | 3,496 | 217 |
Deferred tax assets | 2,799 | 4,045 |
Other non-current assets | 3,105 | 765 |
Total non-current assets | 321,670 | 297,891 |
Total assets | $ 684,887 | $ 653,254 |
LIABILITIES AND EQUITY | ||
Short-term debt | $ 12,949 | $ 2,740 |
Accounts payable and other accrued charges | 95,844 | 69,546 |
Income taxes payable | 15,120 | 10,463 |
Provisions | 3,470 | 12,512 |
Lease obligations | 564 | 1,229 |
Derivative liability | 60,596 | 47,416 |
Current portion of long-term debt | 9,343 | 4,610 |
Liabilities directly associated with the assets held for sale | — | 10,254 |
Other current liabilities | 252 | 647 |
Total current liabilities | 198,138 | 159,417 |
Long-term debt | 79,512 | 64,186 |
Derivative liability | 1,407 | 1,311 |
Provisions | 2,392 | 6,726 |
Deferred tax liabilities | 9,405 | 12,646 |
Lease obligations | 3,170 | 3,244 |
Other non-current liabilities | 395 | 842 |
Total non-current liabilities | 96,281 | 88,955 |
Total liabilities | 294,419 | 248,372 |
Non-controlling interest | 464 | 2,714 |
Equity attributable to common shareholders | 390,004 | 402,168 |
Total equity | 390,468 | 404,882 |
Total liabilities and equity | $ 684,887 | $ 653,254 |
See accompanying notes to this table in Neo's audited consolidated financial statements as at December 31, 2025 and for the year then ended.
CONSOLIDATED RESULTS OF OPERATIONS
($000s) | Three Months Ended December 31, | Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Revenue | $ 120,270 | $ 134,903 | $ 478,793 | $ 475,828 |
Cost of sales | ||||
Cost excluding depreciation and amortization | 82,548 | 94,466 | 337,006 | 343,315 |
Depreciation and amortization | 2,021 | 2,512 | 7,963 | 8,553 |
Gross profit | 35,701 | 37,925 | 133,824 | 123,960 |
Expenses | ||||
Selling, general and administrative | 17,763 | 16,446 | 64,382 | 61,400 |
Share-based compensation | 3,428 | 770 | 11,958 | 3,060 |
Depreciation and amortization | 1,744 | 1,796 | 7,043 | 7,192 |
Research and development | 7,175 | 6,894 | 18,687 | 16,869 |
(Reversal of impairment) / impairment of assets | — | (336) | — | 138 |
Total expenses | 30,110 | 25,570 | 102,070 | 88,659 |
Operating income | 5,591 | 12,355 | 31,754 | 35,301 |
Other (expense) income | (7,270) | 507 | (11,753) | 3,405 |
Finance cost, net | (9,535) | (13,882) | (23,789) | (27,488) |
Foreign exchange gain (loss) | (559) | (4,236) | 7,407 | (4,268) |
Income from operations before income taxes and equity income of associates | (11,773) | (5,256) | 3,619 | 6,950 |
Income tax expense | (3,874) | (7,571) | (14,402) | (17,945) |
Loss from operations before equity income (loss) of associates | (15,647) | (12,827) | (10,783) | (10,995) |
Equity income (loss) of associates (net of income tax) | 19 | 790 | 814 | (2,021) |
Net loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Attributable to: | ||||
Common shareholders | $ (15,639) | $ (12,050) | $ (9,984) | $ (12,946) |
Non-controlling interest | 11 | 13 | 15 | (70) |
Loss per share attributable to common shareholders: | ||||
Basic | $ (0.38) | $ (0.29) | $ (0.24) | $ (0.31) |
Diluted | $ (0.38) | $ (0.29) | $ (0.24) | $ (0.31) |
For additional information, refer to Neo's MD&A for the year ended December 31, 2025.
RECONCILIATION OF NET INCOME TO EBITDA, ADJUSTED EBITDA AND FREE CASH FLOW
($000s, except volume) | Three Months Ended December 31, | Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Sales volume (tonnes) | 2,988 | 3,157 | 13,216 | 12,413 |
Revenue | $ 120,270 | $ 134,903 | $ 478,793 | $ 475,828 |
Net Loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Add back: | ||||
Finance costs, net | 9,535 | 13,882 | 23,789 | 27,488 |
Income tax expense | 3,874 | 7,571 | 14,402 | 17,945 |
Depreciation and amortization included in cost of sales | 2,021 | 2,512 | 7,963 | 8,553 |
Depreciation and amortization included in operating expenses | 1,744 | 1,796 | 7,043 | 7,192 |
EBITDA | 1,546 | 13,724 | 43,228 | 48,162 |
Adjustments to EBITDA: | ||||
Other expense (income) | 7,270 | (507) | 11,753 | (3,405) |
Foreign exchange loss (gain) | 559 | 4,236 | (7,407) | 4,268 |
Equity (income) loss of associates | (19) | (790) | (814) | 2,021 |
Share-based compensation | 3,428 | 770 | 11,958 | 3,060 |
Project start-up and transition costs | 7,583 | 3,594 | 16,928 | 10,154 |
Impairment of assets | — | (336) | — | 138 |
Adjusted EBITDA | $ 20,367 | $ 20,691 | $ 75,646 | $ 64,398 |
Adjusted EBITDA Margin | 16.9 % | 15.3 % | 15.8 % | 13.5 % |
Less: | ||||
Capital expenditures | $ 4,822 | $ 22,818 | $ 23,269 | $ 80,205 |
Free Cash Flow | $ 15,545 | $ (2,127) | $ 52,377 | $ (15,807) |
For additional information, refer to Neo's MD&A for the year ended December 31, 2025.
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED NET INCOME
($000s) | Three Months Ended December 31, | Year ended December 31, | ||
2025 | 2024 | 2025 | 2024 | |
Net Loss | $ (15,628) | $ (12,037) | $ (9,969) | $ (13,016) |
Adjustments to net loss: | ||||
Foreign exchange loss (gain) | 559 | 4,236 | (7,407) | 4,268 |
(Reversal of) Impairment of assets | — | (336) | — | 138 |
Share-based compensation | 3,428 | 770 | 11,958 | 3,060 |
Project start-up & transition costs | 7,583 | 3,594 | 16,928 | 10,154 |
Other items included in other expense (income) | 5,094 | (1,245) | 9,722 | (3,244) |
Tax impact of the above items | (470) | 138 | (770) | 545 |
Adjusted net (loss) income | $ 566 | $ (4,880) | $ 20,462 | $ 1,905 |
Attributable to: | ||||
Common shareholders | $ 555 | $ (4,893) | $ 20,447 | $ 1,975 |
Non-controlling interest | 11 | 13 | 15 | (70) |
Weighted average number of common shares outstanding: | ||||
Basic and diluted (000s) | 41,599 | 41,759 | 41,699 | 41,773 |
Adjusted earnings per share attributable to common shareholders: | ||||
Basic and diluted | $ 0.01 | $ (0.12) | $ 0.49 | $ 0.05 |
For additional information, refer to Neo's MD&A for the year ended December 31, 2025.
SOURCE Neo Performance Materials, Inc.

Analys
Svensk ekonomi
Aktierekommendationer
Bolidens ras
H&M
Analys
Svensk ekonomi
Aktierekommendationer
Bolidens ras
H&M
1 DAG %
Senast

OMX Stockholm 30
−0,90%
(vid stängning)
OMX Stockholm 30
1 DAG %
Senast
2 863,92